Balkrishna Paper Mills Ltd

Balkrishna Paper Mills Ltd closes trading window from 1 October 2026 till the end of 48 hours after the Financial Results for the quarter and half year ended 30 September 2026 are communicated to the Stock Exchanges.

AGM highlights

• AGM held 18 September 2026 at 3:00 PM via VC/OAVM; concluded at 3:49 PM.
• Record date for voting: 11 September 2026.
• Ordinary: Adoption of Audited Financial Statement and reports.
• Ordinary: Re-appointment of Anuraag Poddar as Director liable to retirement by rotation.
• Special: Re-appoint Anuraag Poddar as Chairman and MD for 3 years (11 Feb 2027–10 Feb 2030).
• Special: Re-appoint Manish Malpani as Whole-time Director and CFO for 3 years (9 Dec 2026–8 Dec 2029).
• Special: Re-appoint Prof. Mangesh D. Teli as Non-Executive Independent Director for 5 years (9 Dec 2026–8 Dec 2031).
• All resolutions passed with requisite majorities.

Financial snapshot

• Revenue from operations: ₹473.22 lakh in FY2025-26.
• Total income: ₹484.02 lakh; continuing ops pre-tax: ₹-688.58 lakh.
• Net loss after tax (Total): ₹-651.63 lakh; discontinued segment ₹36.95 lakh profit.
• EPS (Total): ₹-2.02; shares outstanding: 32.22 million.
• Net worth: ₹-17,544.16 lakh; total debt ₹16,605 lakh; cash ₹19.39 lakh.

Operational status

• Ambivali mill discontinued since 13 Nov 2024; machinery to be sold.
• MOU sale consideration: ₹13.618 crore; advance received ₹2.7236 crore.
• Company now trades plastics and packaging materials.
• Assets held for sale/discontinued: ₹1,526.81 lakh at year-end.

Capital structure & liquidity

• Equity share capital ₹32.22 crore; prior rights issue completed.
• Total borrowings ₹16,605 lakh (long-term ₹14,250; short-term ₹2,355).
• Net debt to equity: −0.94x; cash ≈ ₹19.39 lakh; working capital −₹2,463.56 lakh.
• Net cash from operations: −₹428.96 lakh; investing +₹277.72 lakh; financing +₹88.40 lakh.

Developments & strategy

• New business focus: real estate development and allied activities.
• Planning to raise funds for working capital; evaluating options.
• Scheme of Reduction of Share Capital approved; awaiting regulatory approvals.

Governance & controls

• Board: 6 directors; 3 independent; 5 board meetings held.
• Major reappointments: Anuraag Poddar (MD), Manish Malpani (WTD/CFO); Prof. Mangesh D. Teli (Independent).
• Independent Directors meetings held on 23 Dec 2025 and 24 Mar 2026.

Audit & risk disclosures

• Statutory auditor: D S M R & Co; basis for going-concern qualification.
• Secretarial audit: GMJ & Associates; MR-3; no director disqualification.
• Related party transactions include inter-corporate loans; approvals obtained.
• Contingent liabilities include excise, sales tax, GST disputes totaling ₹1,123.18 lakh.

Shareholder matters

• Dividend policy: no dividend declared for FY2025-26.
• CSR and BRSR not applicable for the year.

AGM Details

• AGM date/time/mode: 18 Sep 2026, 3:00 PM IST, VC/OAVM.
• E-voting window: 15–17 Sep 2026; cut-off date: 11 Sep 2026.
• Deemed venue: Registered Office, Mumbai; attendance via VC/OAVM.
• Notice and Annual Report available on the company website.

Key Resolutions

• Ordinary: Adopt Audited Financial Statements and reports for FY 2025-26.
• Ordinary: Appoint director retiring by rotation for re-appointment.
• Special: Re-appoint Anuraag Poddar as Chairman & MD for 3 years.
• Special: Re-appoint Manish Malpani as Whole-time Director & CFO for 3 years.
• Special: Re-appoint Prof. Dr. Mangesh D. Teli as Independent Director for 5 years.

Dividend

• Dividend: No dividend proposed for the year.

Directors & Management Changes

• Re-appointment of Anuraag Poddar as Chairman and Managing Director.
• Re-appointment of Manish Malpani as Whole-time Director & CFO.
• Re-appointment of Prof. Dr. Mangesh D. Teli as Independent Director.

Auditors & Related Parties

• Statutory Auditors: DSMR & Co; five-year tenure through 2028.
• Secretarial Auditors: GMJ & Associates; five-year tenure through 2030.
• Cost Auditors: not appointed from 2026-27 due to discontinued operations.
• Material related party transactions include inter-corporate loans with related parties.

Other Material Approvals

• Scheme of Reduction of Share Capital approved; subject to member and NCLT approvals.
• Commencement of new business: real estate development; main object clauses updated.
• Related Party Transaction policy published on the company website.

Financial results & going concern

• Board approves unaudited Q1 FY26 results for quarter ended 30 June 2026.
• Net worth negative Rs 17,723.83 Lakhs as of 30 June 2026.
• Ambivali plant manufacturing activity discontinued.
• Going concern depends on generation of expected cash flows.
• Auditor's review did not express an audit opinion.
• Extract to be published in newspapers; results on BPML, BSE and NSE websites.
• Board meeting held on 12 August 2026; 3:00 PM to 6:00 PM.

Meeting Details

• Date: 12 August 2026; time not disclosed; venue: Registered Office, Mumbai.

Key Agenda Items

• To consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Other Notes

• Trading window closure from 1 July 2026 until 48 hours after results on 12 August 2026.

Dematerialisation processing and listing status

• Securities received for dematerialisation were confirmed to the depositories.
• Securities dematerialised have been listed on the stock exchanges where earlier issues are listed.
• Physical certificates for dematerialisation were mutilated and cancelled.
• Depository's name substituted as registered owner within prescribed timelines.
• Certificate confirming processing issued by the registrar.